Comparing Intraneural Facilitation Therapy and Standard Physical Therapy for Treating Type 2 Diabetic Peripheral Neuropathy in Adults Aged 45 to 85
Led by Loma Linda University · Updated on 2025-11-19
40
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating two treatment approaches for Peripheral Neuropathy in people with Type 2 Diabetes, a common and costly complication causing symptoms like pain, numbness, and tingling. This study aims to better understand how Intraneural Facilitation Therapy INF4 Therapy, a non-invasive manual technique, compares to standard physical therapy in improving neuropathy symptoms and underlying physiological functions.
Participants will be randomly assigned to one of two groups one receiving nine 60-minute sessions of INF4 Therapy, which involves specific manual holds to improve blood flow in nerves, and the other receiving nine 60-minute sessions of standard physical therapy focused on muscle stretching, balance, and strengthening exercises. Treatments occur over 6 weeks during 11 study visits, including initial and follow-up assessments.
Throughout the study, participants will undergo various tests including pain assessments, heart rate variability monitoring using the Welltory App, vascular imaging, blood oxygen and flow measurements, and blood draws to measure inflammation and blood sugar control. These evaluations occur at several visits to monitor changes and treatment effects. The study will analyze these measures to understand how each therapy impacts nerve function, blood flow, and inflammation over the 6-week period.
CONDITIONS
Brief Title
A Physiologic Comparison of Two Approaches to Treating Peripheral Neuropathy
Research Team
M
Mark Bussell, DPT, OCS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Intraneural Facilitation Therapy
Standard Physical Therapy
What it is
A technique that uses sequential manual holds and stretches on nerves in the affected limb to improve blood flow into areas with restricted circulation.
A course of standard physical therapy, with stretching, balance, and strengthening exercises targeting neuropathy symptoms.
Role in this trial
Investigational therapy being tested for effects on heart rate variability and neuropathy symptoms.
Active comparator arm using established physical therapy methods.
Primary use
Intended to improve blood flow to nerves and reduce symptoms for people with diabetic peripheral neuropathy.
Applied to maintain or improve mobility, balance, and strength, alleviating neuropathy symptoms in diabetes.
How it is given or performed
Specially trained providers perform a series of three manual techniques and stretches on nerves of the affected limb during each session.
Participants receive routine physical therapy including stretching, balance, and strengthening exercises under supervision of a physical therapist.
Evidence status
Early studies have examined its effects on neuropathy symptoms, but robust evidence in larger or diverse populations is not yet established.
Regarded as an established non-drug therapy for diabetic peripheral neuropathy with published evidence supporting its role in symptom improvement and physical function.
Important limitations
Limited by the small number of studies and participants, and lack of long-term follow-up or multi-center trials.
Requires repeated therapist-guided sessions and may not fully resolve symptoms for all patients, particularly when neuropathy is advanced.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 45Years - 85Years
All Genders
Eligibility Criteria
You may qualify if you...
Between the ages of 45 and 85
Diagnosed moderate to severe type II diabetic neuropathy with symptoms such as numbness, tingling, burning, sharp pain, or increased sensitivity
Diagnosis confirmed by a physician
Access to a cellphone with Android 5.0 or later or iOS 14.0 or later
You will not qualify if you...
Medical conditions likely to cause decline in the next 6 months, such as chemotherapy or radiation
Lower extremity amputations
Open wounds
Active drug or alcohol misuse
Chronic liver disease
Active inflammations
Neuropathies not related to diabetes, including B12 deficiency and Charcot Marie Tooth
Morbid obesity
Pregnancy
Taking beta blockers
Unable to maintain steady fingers or operate a cellphone
Smoking or using marijuana
Having a pacemaker
Allergies to cobalt, chrome, or nickel
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for informed consent and eligibility confirmation
Treatment
Duration - Approximately 6 weeks
Participants receive nine 60-minute sessions of either Intraneural Facilitation Therapy or standard physical therapy to treat peripheral neuropathy symptoms.
11 sessions with assessments on sessions 1, 2, 5, 10, and 11
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing Intraneural Facilitation Therapy and Standard Physical Therapy for Treating Type 2 Diabetic Peripheral Neuropathy in Adults Aged 45 to 85
Effects of Walkasins Use on Gait and Balance in Peripheral Neuropathy Patients with Balance Problems A Randomized Controlled Trial
A Randomized Trial Comparing a Whole-Food, Plant-Based Diet Versus Medication for Treating Painful Diabetic Neuropathy
Study of the Wearable Walkasins Device to Improve Walking, Balance, and Physical Activity in Adults with Peripheral Neuropathy
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
Reliability of microvascular responsiveness measures derived from near-infrared spectroscopy across a variety of ischemic periods in young and older individuals.
Danilo Iannetta, Erin Calaine Inglis, Rogerio N Soares...
Proinflammatory cytokines predict the incidence of diabetic peripheral neuropathy over 5 years in Chinese type 2 diabetes patients: A prospective cohort study.